| HBAN |
Report |
Adjusted EPS |
BEAT |
pred ~$0.39 vs. cons $0.38 |
MEDIUM |
| HBAN |
Report |
Net interest income |
IN-LINE |
pred ~$1.94B vs. cons $1.93B |
MEDIUM |
| HBAN |
Report |
Noninterest income |
IN-LINE |
pred ~$0.70B vs. cons $0.70B |
MEDIUM |
| HBAN |
Guide |
2026 exit net interest margin |
UNCHANGED |
guide ~3.28% vs. cons 3.28% (4Q26 exit) |
MEDIUM |
| HBAN |
Guide |
2026 fee-income growth |
UNCHANGED |
guide ~32% vs. cons 32% (FY26) |
MEDIUM |
| HBAN |
Guide |
Combined Veritex and Cadence cost synergies |
UNCHANGED |
guide ~$435M vs. cons $435M (4Q26 run-rate) |
HIGH |
| HBAN |
Guide |
2027 adjusted EPS target |
UNCHANGED |
guide ~$1.92 vs. cons $1.92 (FY27) |
MEDIUM |
| HBAN |
Return |
Day-1 residual (stock − beta × S&P 500) |
+3.0% |
— |
MEDIUM |
| HBAN |
Return |
5-day cumulative residual |
+4.5% (FOLLOW-THROUGH) |
A modest ~$0.01 EPS beat versus ~$0.38 consensus, paired with intact ~$435M 4Q26 synergy delivery and a reaffirmed ~$1.92 FY27 EPS target, should lift out-period estimates rather than leave the beat as a one-quarter fee or accounting event. |
MEDIUM |